Therapeutic effects of ephrin B receptor 2 inhibitors screened by molecular docking on cutaneous squamous cell carcinoma.
Conclusion: EphB2 small-molecule inhibitors had anti-CSCC effects, establishing a solid theoretical basis for clinical research.
PMID: 32338086 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Dermatology | Epithelial Cancer | Skin | Skin Cancer | Squamous Cell Carcinoma | Study